The effect of scoploamine (0.6 mg) and physostigmine (1.0 mg) on higher nervous activity in man, followed-up during 5 hours after application.
D000328:Adult; D001245:Association Learning / Q000187:drug effects*; D004347:Drug Interactions; D005260:Female; D006613:Higher Nervous Activity / Q000187:drug effects*; D006801:Humans; D007858:Learning / Q000187:drug effects*; D008297:Male; D010830:Physostigmine / Q000494:pharmacology*; D012601:Scopolamine / Q000494:pharmacology*; D013997:Time Factors
D010830:Physostigmine; D012601:Scopolamine